Jonathan F. Lovell

Self-disclosure for mental health practitioners can have benefits for the therapeutic relationship. Most practitioners, however, are wary of doing so, or do not know how to navigate this. This paper aims to present a comprehensive framework to assist mental health practitioners when choosing to self-disclose lived experiences. This framework was created by a working group of academics, clinicians, service users and recovery workers, based on an international project investigating self-disclosure among professionals. Results from this project informed the content of this framework, considering theoretical models of supervision to guide development. The Sharing Lived Experiences Framework (SLEF) details six areas for practitioners to consider: Preparedness, Confidence, Competence, Relevance, Comfort and Supervision. The connection between preparedness and supervision is emphasised. Preliminary data on the SLEF indicates that staff felt more able to navigate disclosure after training on this framework. To the authors’ knowledge, this is the first comprehensive framework to guide practitioners through the disclosure process; from planning, to in-the-moment considerations, to post-disclosure reflection. Although limited available data exist on clinical utility, the SLEF crucially provides a framework for supervision discussions and guided self-reflection for a full range of practitioners on a range of lived experiences.

Three paramagnetic Co^II macrocyclic complexes containing 2‐hydroxypropyl pendant groups, 1,1′,1′′,1′′′‐(1,4,8,11‐tetraazacyclotetradecane‐1,4,8,11‐tetrayl)tetrakis‐ (propan‐2‐ol) ([Co(L1)]²⁺, 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(propan‐2‐ol) ([Co(L2)]²⁺), and 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(octadecan‐2‐ol) ([Co(L3)]²⁺) were synthesized to prepare transition metal liposomal chemical exchange saturation transfer (lipoCEST) agents. In solution, ([Co(L1)]²⁺) forms two isomers as shown by ¹H NMR spectroscopy. X‐ray crystallographic studies show one isomer with 1,8‐pendants in cis‐configuration and a second isomer with 1,4‐pendants in trans‐configuration. The [Co(L2)]²⁺ complex has 1,8‐pendants in a cis‐configuration. Remarkably, the paramagnetic‐induced shift of water ¹H NMR resonances in the presence of the [Co(L1)]²⁺ complex is as large as that observed for one of the most effective Ln^III water proton shift agents. Incorporation of [Co(L1)]²⁺ into the liposome aqueous core, followed by dialysis against a solution of 300 mOsm L⁻¹ produces a CEST peak at 3.5 ppm. Incorporation of the amphiphilic [Co(L3)]²⁺ complex into the liposome bilayer produces a more highly shifted CEST peak at −13 ppm. Taken together, these data demonstrate the feasibility of preparing Co^II lipoCEST agents.

Three paramagnetic Co^II macrocyclic complexes containing 2‐hydroxypropyl pendant groups, 1,1′,1′′,1′′′‐(1,4,8,11‐tetraazacyclotetradecane‐1,4,8,11‐tetrayl)tetrakis‐ (propan‐2‐ol) ([Co(L1)]²⁺, 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(propan‐2‐ol) ([Co(L2)]²⁺), and 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(octadecan‐2‐ol) ([Co(L3)]²⁺) were synthesized to prepare transition metal liposomal chemical exchange saturation transfer (lipoCEST) agents. In solution, ([Co(L1)]²⁺) forms two isomers as shown by ¹H NMR spectroscopy. X‐ray crystallographic studies show one isomer with 1,8‐pendants in cis‐configuration and a second isomer with 1,4‐pendants in trans‐configuration. The [Co(L2)]²⁺ complex has 1,8‐pendants in a cis‐configuration. Remarkably, the paramagnetic‐induced shift of water ¹H NMR resonances in the presence of the [Co(L1)]²⁺ complex is as large as that observed for one of the most effective Ln^III water proton shift agents. Incorporation of [Co(L1)]²⁺ into the liposome aqueous core, followed by dialysis against a solution of 300 mOsm L⁻¹ produces a CEST peak at 3.5 ppm. Incorporation of the amphiphilic [Co(L3)]²⁺ complex into the liposome bilayer produces a more highly shifted CEST peak at −13 ppm. Taken together, these data demonstrate the feasibility of preparing Co^II lipoCEST agents.